Caseware UK (AP4) 2023.0.135 2023.0.135 2025-03-312025-03-312024-04-01falseProvides support for clinical skills teaching for students or NHS staff1514falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 05105852 2024-04-01 2025-03-31 05105852 2023-04-01 2024-03-31 05105852 2025-03-31 05105852 2024-03-31 05105852 c:CompanySecretary1 2024-04-01 2025-03-31 05105852 c:Director1 2024-04-01 2025-03-31 05105852 c:RegisteredOffice 2024-04-01 2025-03-31 05105852 d:FurnitureFittings 2024-04-01 2025-03-31 05105852 d:FurnitureFittings 2025-03-31 05105852 d:FurnitureFittings 2024-03-31 05105852 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05105852 d:OfficeEquipment 2024-04-01 2025-03-31 05105852 d:OfficeEquipment 2025-03-31 05105852 d:OfficeEquipment 2024-03-31 05105852 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05105852 d:ComputerEquipment 2024-04-01 2025-03-31 05105852 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05105852 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 05105852 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 05105852 d:CurrentFinancialInstruments 2025-03-31 05105852 d:CurrentFinancialInstruments 2024-03-31 05105852 d:Non-currentFinancialInstruments 2025-03-31 05105852 d:Non-currentFinancialInstruments 2024-03-31 05105852 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 05105852 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 05105852 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 05105852 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 05105852 d:ShareCapital 2025-03-31 05105852 d:ShareCapital 2024-03-31 05105852 d:RetainedEarningsAccumulatedLosses 2025-03-31 05105852 d:RetainedEarningsAccumulatedLosses 2024-03-31 05105852 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 05105852 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 05105852 c:FRS102 2024-04-01 2025-03-31 05105852 c:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 05105852 c:FullAccounts 2024-04-01 2025-03-31 05105852 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05105852 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:ExternallyAcquiredIntangibleAssets 2024-04-01 2025-03-31 05105852 2 2024-04-01 2025-03-31 05105852 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2024-04-01 2025-03-31 05105852 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Registered number: 05105852












CLINICAL SKILLS LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED
 31 MARCH 2025



















 


img6130.png
01483 755 399
hamlyns.com

 
CLINICAL SKILLS LIMITED
 

COMPANY INFORMATION


Director
Peter Michael Gardiner 




Company secretary
Sharon Kingman



Registered number
05105852



Registered office
Sundial House
High Street

Horsell

Woking

GU21 4SU




Accountants
Hamlyns Limited
Chartered Accountants

Sundial House

High Street

Horsell

Woking

GU21 4SU






 
CLINICAL SKILLS LIMITED
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF CLINICAL SKILLS LIMITED
FOR THE YEAR ENDED 31 MARCH 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Clinical Skills Limited for the year ended 31 March 2025 which comprise the balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

As a member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/membership/
regulations-standards-and-guidance.


This report is made solely to the director of Clinical Skills Limited in accordance with the terms of our engagement at hamlyns.com/tac. Our work has been undertaken solely to prepare for your approval the financial statements of Clinical Skills Limited and state those matters that we have agreed to state to the director of Clinical Skills Limited in this report in accordance with ICAEW Technical release TECH07/16AAF . To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Clinical Skills Limited and its director for our work or for this report.
 
 
It is your duty to ensure that Clinical Skills Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Clinical Skills Limited. You consider that Clinical Skills Limited is exempt from the statutory audit requirement for the year.
 
 
We have not been instructed to carry out an audit or review of the financial statements of Clinical Skills Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.





Hamlyns Limited
 
Chartered Accountants
  
Sundial House
High Street
Horsell
Woking
GU21 4SU

22 December 2025
Page 1

 
CLINICAL SKILLS LIMITED
REGISTERED NUMBER: 05105852

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
£
£

Fixed assets
  

Intangible assets
 4 
756,998
547,597

Tangible assets
 5 
27,879
38,514

  
784,877
586,111

Current assets
  

Stocks
  
2,674
30

Debtors: amounts falling due within one year
 6 
116,199
137,003

Cash at bank and in hand
  
333,194
461,945

  
452,067
598,978

Creditors: amounts falling due within one year
 7 
(665,380)
(598,664)

Net current (liabilities)/assets
  
 
 
(213,313)
 
 
314

Total assets less current liabilities
  
571,564
586,425

Creditors: amounts falling due after more than one year
 8 
(79,067)
(72,029)

Provisions for liabilities
  

Deferred tax
 9 
(146,179)
(146,527)

  
 
 
(146,179)
 
 
(146,527)

Net assets
  
346,318
367,869


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
346,218
367,769

  
346,318
367,869

Page 2

 
CLINICAL SKILLS LIMITED
REGISTERED NUMBER: 05105852

BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 December 2025.




___________________________
Peter Michael Gardiner
Director

The notes on pages 4 to 10 form part of these financial statements.

Page 3

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Clinical Skills Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 05105852 and registered office address is Sundial House, High Street, Horsell, Woking, GU21 4SU. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 4

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

  
2.3

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Page 5

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.7

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25%
reducing balance
Computer equipment
-
25%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 6

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 15 (2024 - 14).


4.


Intangible assets




Development expenditure

£



Cost


At 1 April 2024
547,597


Additions
264,166



At 31 March 2025

811,763



Amortisation


Charge for the year on owned assets
54,765



At 31 March 2025

54,765



Net book value



At 31 March 2025
756,998



At 31 March 2024
547,597

Page 7

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
 
           4.Intangible assets (continued)




5.


Tangible fixed assets





Fixtures and fittings
Computer equipment
Total

£
£
£



Cost or valuation


At 1 April 2024
4,346
147,746
152,092


Additions
145
-
145



At 31 March 2025

4,491
147,746
152,237



Depreciation


At 1 April 2024
2,420
111,159
113,579


Charge for the year on owned assets
490
10,289
10,779



At 31 March 2025

2,910
121,448
124,358



Net book value



At 31 March 2025
1,581
26,298
27,879



At 31 March 2024
1,926
36,588
38,514


6.


Debtors

2025
2024
£
£


Trade debtors
104,329
122,021

Prepayments and accrued income
11,870
14,982

116,199
137,003


Page 8

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
6,342
10,742

Corporation tax
38,489
8,331

Other taxation and social security
19,304
17,724

Other creditors
13,600
29,925

Accruals and deferred income
587,645
531,942

665,380
598,664



8.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Accruals and deferred income
79,067
72,029

79,067
72,029


Page 9

 
CLINICAL SKILLS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


Deferred taxation




2025


£






At beginning of year
(146,528)


Charged to profit or loss
349



At end of year
(146,179)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(146,179)
(146,528)

(146,179)
(146,528)


10.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held
separately from those of the Company in an independently administered fund. The pension cost charge
represents contributions payable by the Company to the fund and amounted to £71,535 (2023 - £57,608).
There were contributions payable at the balance sheet date of £20,792 (2023 - £1,347).


Page 10